Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>AI and Biotech Startup Earendil Labs Mulls HK Listing to Raise USD500M: Wire
Recommend 6 Positive 8 Negative 2 |
||||
|
||||
|
The biotech startup Earendil Labs, which focuses on AI drug development, is weighing a listing in Hong Kong, Bloomberg reported, citing people with the knowledge of the matter. The company is collaborating with CICC and Morgan Stanley on IPO matters, with a potential fundraising amount of up to USD500 million. Yesterday (12th), WUXI BIO (02269.HK) announced that it had clinched a strategic cooperation agreement with Earendil Labs. WUXI BIO will provide integrated development and production services for several bispecific/ multi-specific antibodies and antibody-drug conjugates (ADC) in Earendil Labs' pipeline, which are used to treat autoimmune diseases, tumors, and other conditions. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
